| Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 02089-16, 2017 | 111 | 2017 |
| Acute kidney injury in patients treated with vancomycin and piperacillin‐tazobactam: a retrospective cohort analysis WC Rutter, DR Burgess, JC Talbert, DS Burgess Journal of hospital medicine 12 (2), 77-82, 2017 | 78 | 2017 |
| Increasing incidence of multidrug resistance among cystic fibrosis respiratory bacterial isolates WC Rutter, DR Burgess, DS Burgess Microbial drug resistance 23 (1), 51-55, 2017 | 67 | 2017 |
| Incidence of acute kidney injury among patients treated with piperacillin-tazobactam or meropenem in combination with vancomycin WC Rutter, DS Burgess Antimicrobial agents and chemotherapy 62 (7), 10.1128/aac. 00264-18, 2018 | 50 | 2018 |
| Nephrotoxicity in patients with or without cystic fibrosis treated with polymyxin B compared to colistin RL Crass, WC Rutter, DR Burgess, CA Martin, DS Burgess Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02329-16, 2017 | 44 | 2017 |
| Influence of β-lactam infusion strategy on acute kidney injury SE Cotner, WC Rutter, DR Burgess, KL Wallace, CA Martin, DS Burgess Antimicrobial agents and chemotherapy 61 (10), 10.1128/aac. 00871-17, 2017 | 40 | 2017 |
| Acute Kidney Injury in Patients Treated with IV Beta‐Lactam/Beta‐Lactamase Inhibitor Combinations WC Rutter, DS Burgess Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (5 …, 2017 | 31 | 2017 |
| Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL-and KPC-producing Enterobacter cloacae B Kulengowski, WC Rutter, JJ Campion, GC Lee, DJ Feola, DS Burgess Diagnostic Microbiology and Infectious Disease 92 (3), 262-266, 2018 | 26 | 2018 |
| Persistent opioid use after combat injury and subsequent long-term risk of abuse: a retrospective cohort study CA Beyer, E Poltavskiy, LE Walker, W Pettey, Y Suo, A Redd, AG Rittel, ... Annals of surgery 274 (6), e957-e965, 2021 | 15 | 2021 |
| Impact of total body weight on rate of acute kidney injury in patients treated with piperacillin–tazobactam and vancomycin WC Rutter, RG Hall 2nd, DS Burgess American Journal of Health-System Pharmacy 76 (16), 1211-1217, 2019 | 14 | 2019 |
| Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients RZ Thompson, CA Martin, DR Burgess, WC Rutter, DS Burgess Journal of Cystic Fibrosis 15 (5), 660-663, 2016 | 14 | 2016 |
| Nephrotoxicity and clinical outcomes in patients treated with nafcillin or cefazolin WC Rutter, DS Burgess Open Forum Infectious Diseases 3 (suppl_1), 302, 2016 | 2 | 2016 |
| Evaluation of an Opioid Overdose Composite Risk Score Cutoff in Active Duty Military Service Members JR Dunham, KB Highland, RC Costantino, W Cliff Rutter, AG Rittel, ... Pain Medicine 23 (11), 1902-1907, 2022 | 1 | 2022 |
| Hospitalization rate differences among cancer patients on biologics and biosimilars. S Reddy, W Rutter, W Cavers, E Avalos-Reyes, KA Johnson Journal of Clinical Oncology 40 (16_suppl), e13530-e13530, 2022 | 1 | 2022 |
| Association of socioeconomic status with adherence to oral agents in patients with multiple myeloma. W Rutter, S Prakash, W Cavers, E Avalos-Reyes, KA Johnson, ... Journal of Clinical Oncology 40 (16_suppl), 8023-8023, 2022 | 1 | 2022 |
| Comparative Rates of Nephrotoxicity in Patients Treated With Piperacillin-Tazobactam and Meropenem: A Retrospective Cohort Study. WC Rutter, DS Burgess Open Forum Infectious Diseases 3 (suppl_1), 1814, 2016 | 1 | 2016 |
| Development of Acute Kidney Injury in Patients treated with Polymyxin B Compared to Colistimethate Sodium RL Crass, WC Rutter, DR Burgess, C Martin, DS Burgess Open Forum Infectious Diseases 3 (suppl_1), 1802, 2016 | 1 | 2016 |
| Incidence of Acute Kidney Injury in Patients Treated With Vancomycin and Piperacillin/Tazobactam WC Rutter, JC Talbert, DS Burgess Open Forum Infectious Diseases 2 (suppl_1), 125, 2015 | 1 | 2015 |
| Evaluation of Healthcare Utilization in Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus J Park, WC Rutter, E Avalos-Reyes, C Liu, W Cavers, D Verbrugge, ... ARTHRITIS & RHEUMATOLOGY 75, 323-325, 2023 | | 2023 |
| Impact of Social Determinants of Health Factors on Medication Adherence in Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus J Park, WC Rutter, E Avalos-Reyes, C Liu, W Cavers, D Verbrugge, ... ARTHRITIS & RHEUMATOLOGY 75, 328-330, 2023 | | 2023 |
